3LIU Z S,JIN D P,CHEN Z H.Management of Nosocomial Infections (医院感染管理学)[M].Beijing:Military Medical Publishing House,2001:314-317.
4The U.S.Agency for International Development (USAID).How to Investigate Antimicrobial Drug Use in Hospitals:Selected Indicators[C].Arlington:Management Sciences for Health,Inc.,2002:8-25,30.
5WHO.How to Investigate Drug Use in Health Facilities:Selected Drug Use Indicators[C].Geneva:WHO,1993.
6WHO/INRUD.How to Use Applied Qualitative Methods to Design Drug Use Interventions[C].Geneva:WHO,1996:118-120.
7WHO/INRUD/USAID.Interventions and Strategies to Improve the Use of Antimicrobials in Developing Countries[C].Arlington:Management Sciences for Health,Inc.,2001:11-15.
4World Health Organization(WHO). The selection and use of essential medicines:Report o{ the WHO Expert Commit- tee,2007 (including the 15th Model List of Essential Medi- cines) [EB/OL]. Geneva, World Health Organization, 2007 (WHO Technical Report Series, No. 946). www. who. int/ entity/medicines/publications/essentialmeds _ committeere- ports/TRS946 EMedLib. pdf.
5WHO/DAP/INRUD. How to investigate drug use in health facilities, selected drug use indicators. Geneva, World Health Organization, 1993. http://apps, who. int/medicinedocs/ pdf/s2289e/s2289e, pd{.
6Kathleen Holloway,Liset van Dijk. The world medicines sit- uation 2011: Rational use of medicines. Geneva, World Health Organization, 2011. WHO/EMP/MIE/2011. 2. 2. ht- tp://www, who. int/medicines/areas/policy/world_ medi- cines_situation/ WMS_ch14_wRational. pdf.
